Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangyi Lin

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2025
ER-phagy Activation by AMFR Attenuates Cardiac Fibrosis Post-Myocardial Infarction via mTORC1 PathwayZhixiang Wang, Kaifan Niu, Wei Liu, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: A 3-year survivorship analysisYangyi Lin, Lingpin Pang, Shian Huang, et al.
Cardiology|March 23, 2023
A Nomogram for Predicting 3-Year Mortality in Patients with Pulmonary Hypertension due to Left Heart Failure: A Retrospective Analysis of a Prospective Registry StudyYangyi Lin, Lingpin Pang, Shian Huang, et al.
Frontiers in Cardiovascular Medicine|August 19, 2022
The prevalence and survival of pulmonary hypertension due to left heart failure: A retrospective analysis of a multicenter prospective cohort studyYangyi Lin, Lingpin Pang, Shian Huang, et al.
The American Journal of Cardiology|February 21, 2017
Relation of Low-Density Lipoprotein Cholesterol to Ischemic Stroke in Patients With Nonvalvular Atrial FibrillationZhiyong Qi, Hua Chen, Zhichao Wen, et al.
Respirology (Carlton, Vic.)|March 18, 2024
Effect of off-label targeted drugs on long-term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registryWanying Xia, Yuling Qian, Yangyi Lin, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 31, 2025
Pulchinenoside E2: A dual-functional STAT3 and autophagy inhibitor with potent anti-metastatic activity in triple-negative breast cancerDongning Zheng, Junfang Shu, Benjian Gao, et al.
Respirology (Carlton, Vic.)|March 16, 2022
Characteristics, goal-oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registryRuilin Quan, Gangcheng Zhang, Zaixin Yu, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2025
ER-phagy Activation by AMFR Attenuates Cardiac Fibrosis Post-Myocardial Infarction via mTORC1 PathwayZhixiang Wang, Kaifan Niu, Wei Liu, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: A 3-year survivorship analysisYangyi Lin, Lingpin Pang, Shian Huang, et al.
Cardiology|March 23, 2023
A Nomogram for Predicting 3-Year Mortality in Patients with Pulmonary Hypertension due to Left Heart Failure: A Retrospective Analysis of a Prospective Registry StudyYangyi Lin, Lingpin Pang, Shian Huang, et al.
Frontiers in Cardiovascular Medicine|August 19, 2022
The prevalence and survival of pulmonary hypertension due to left heart failure: A retrospective analysis of a multicenter prospective cohort studyYangyi Lin, Lingpin Pang, Shian Huang, et al.
The American Journal of Cardiology|February 21, 2017
Relation of Low-Density Lipoprotein Cholesterol to Ischemic Stroke in Patients With Nonvalvular Atrial FibrillationZhiyong Qi, Hua Chen, Zhichao Wen, et al.
Respirology (Carlton, Vic.)|March 18, 2024
Effect of off-label targeted drugs on long-term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registryWanying Xia, Yuling Qian, Yangyi Lin, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 31, 2025
Pulchinenoside E2: A dual-functional STAT3 and autophagy inhibitor with potent anti-metastatic activity in triple-negative breast cancerDongning Zheng, Junfang Shu, Benjian Gao, et al.
Respirology (Carlton, Vic.)|March 16, 2022
Characteristics, goal-oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registryRuilin Quan, Gangcheng Zhang, Zaixin Yu, et al.
Pageof 2